Testimonials

Hear what people have to say

Rated 5 out of 5
Thank you for the opportunity to share insights. The fireside conversation format brought out the best of our knowledge and experiences.
Anne Woollett
Associate Director Operations and Strategy, Deakin Trials Hub
Deakin University
Rated 5 out of 5
It was a pleasure to speak at the inaugural Melbourne PPM Summit. Two days filled with valuable insights, learning and meaningful connections across our thriving life sciences sector.
Taneen Hisgrove
Clinical Research Professional Clinical Trial Strategy and Execution, Biotech and CRO Global Clinical Operations
Rated 5 out of 5
I had the privilege of speaking at the inaugural AU Pharma and Biotech Project Program and Portfolio Management Conference hosted by Why Summits. A stellar panel discussion on external partnerships and collaborations in portfolio execution. The atmosphere was inspiring, full of curiosity, enthusiasm and thoughtful industry conversations.
Amanda Xiaoqing Mao
Managing Director and Founder
Acurit Medical Communications Pty Ltd

Rated 5 out of 5
Great to participate in the Why Summits Biotech & Pharma PPM Conference last week. A focused, dialogue driven event for leaders managing complex programs in life sciences. Thank you for the opportunity to share insights with industry peers
Lauren Eve Kelly
Senior Director Targeted Translation Research Accelerator, Diabetes & Cardiovascular Disease
MTPConnect
Rated 5 out of 5
It was an honor to be part of such a prestigious event.
Dhawal Upadhyay, PMP®
General Manager – Global Program Management
Intas Pharmaceuticals
Rated 5 out of 5
The networking opportunities were invaluable.
Phil Wolf
SVP, On Demand Products
PDWare
Rated 5 out of 5
An engaging and professional event.
Thomas Seener
Executive Director
The One Project Source, LLC
Rated 5 out of 5
An outstanding few days of industry-relevant topics.
Mike Fitzpatrick
Vice President of Business Development & Operations
Umoja Biopharma
Rated 5 out of 5
Well organized, well attended, high engagement!
Dave Penndorf
Product and Project Management Advisor
Groundswell Pharma Consulting
Rated 5 out of 5
An empowering conference.
Pav Rishiraj
Director, Head of Pharmacovigilance
Ipsen
Rated 5 out of 5
The perfect opportunity to learn from and network with peers, share challenges, and discuss fresh approaches.
Adeline L.
Head of Project Management Operations
Sanofi
Rated 5 out of 5
Engaging with such an experienced group of professionals was a great learning experience overall.
Anusha Sivaramakrishnan
Executive Director, Head – Enterprise Project Management and Governance
Arvinas
Rated 5 out of 5
It was an honor and a privilege to speak at the Why Summits Conference. The entire event was informative and engaging; and executed in the utmost excellence.
Kelvin Roddy, Ph.D, MBA
R&D Director Program and Portfolio Management
Alexion Pharmaceuticals
Rated 5 out of 5
The perfect size – big enough to attract diverse and talented people, but small enough for meaningful networking.
Rebecca Rudicell, PhD
Translational Program Management (Oncology)
Takeda
Rated 5 out of 5
An event where everyone could participate in the conversation. A great mix of Panel discussion, round table, and presentations that give the ability to network and meet everyone in the room.
Kelly Keen
Independent Consultant
Rated 5 out of 5
Digital Health in combination with PPM (previous Future of Health Streams) were a fantastic idea. Wish I could split myself to hear both DH and PPM presentations. Networking events have been outstanding!
Irena Prasilova
Business Operation Director
Merck
Rated 5 out of 5
Future of Health 2019 has set a new bar for healthcare conferences - a remarkable blend of high-level speakers, genuinely interactive networking sessions, thought-provoking panels, festive outdoor events, and a dedicated staff to make it all happen. Well done!
Nataraj Dasgupta
Vice President of Analytics
RxDataScience
Rated 5 out of 5
A fantastic experience, from the great networking opportunities and startup presentations to the panel discussions on truly appropriate topics.
Shafique Ur Rehman
CEO
Rehman Medical Institute
Rated 5 out of 5
Very well planned and organized. Attendees from a great diversity of backgrounds made the experience excellent.
Catherine Brown
Director
Benguela Health
Rated 5 out of 5
Future of Health made networking and relationship building easy, I loved it.
Daniel Zand
Founder & CEO
Holistal
Rated 5 out of 5
High-quality speakers and attendees, a great mix between healthcare providers, life science companies, providers of digital health & AI solutions, and investors
John Mulcahy
CEO
HealthGenuity
Rated 5 out of 5
Organization was flawless and topics, speakers, and delegates were carefully selected. One of the few conferences I have been that you meet like-minded people and who are open to sharing experiences and knowledge. Lots of fun as well.
Andreas Panteli
Digital and Data Leader
Novartis
Rated 5 out of 5
We were proud to be Sponsors for the 31st European Life Sciences Project & Portfolio Management Conference in London. Two really energising days of learning and connection. Huge thanks to Why Summits for such a well-run event. The presentations, panels and workshops sparked great conversations around portfolio strategy, governance, risk and innovation across the sector. Most of all, it was fantastic to reconnect with familiar faces and meet new Life Sciences leaders who share the same passion for PPM.
Merryn Horneman
Life Sciences Delivery Partner
MiGSO-PCUBED
Rated 5 out of 5
Thank you, Richard, for an insightful masterclass. The content and discussions were invaluable, and I truly appreciated the opportunity to connect with knowledgeable peers. I particularly found the emphasis on securing executive sponsorship crucial for effective implementation. Hope to see you soon in future sessions.
Lucy Y.
Global Pipeline Forecasting , Takeda
Rated 5 out of 5
Thank you very much. It was a pleasure to meet you and to attend this masterclass.
Fanny Weber Harounen
Deputy Director - End to End Project Controller, Sanofi
Rated 5 out of 5
The value gained from the masterclass far exceeded the cost.
Iris Faßmann
Project Operational Data Lead, Merck
Rated 5 out of 5
Many thanks for the masterclass. I enjoyed it immensely and look forward to implementing the learnings into my work. I also hope we’ll meet again.
Lucas Alexander Husum
R&D Business Associate | R&D Project and Portfolio Management, Lundbeck
Rated 5 out of 5
Thanks a lot for your excellent course.It was comprehensive, well-founded, and practice-oriented. I learned a lot and found the learning atmosphere very pleasant. I truly appreciate your expertise and would be happy to come back. I’m particularly interested in your Product Portfolio Management course, especially if offered online or in Europe.
Matthias Pruckner
Senior Product Manager Portfolio Management, Getinge - Maquet Cardiopulmonary GmbH
Rated 5 out of 5
Thank you so much for teaching me about Risk and Portfolio Management. I deeply enjoyed the class and would be interested in joining one of your dedicated Portfolio Management courses in the future.
Michaela Fesenfeld
Commercial Director Targeted Protein Degradation, Merck Innovation Center
Rated 5 out of 5
It was awesome. Thank you so much for laying out such a great system. Your relentless channeling of value through the pipeline was a journey in correct computation, value estimation, and sound decision thinking. It’s rare that I see someone’s work, especially around the choice of statistical methods and computation assumptions, and think, “This is the right way to do it.” I also really liked the insights on binomial probability estimates, milestone passage, business outcomes, and discounting in decision trees. You are a master of value tracking.
Fiore, Steven J
Director, Operational Excellence and DFR (Design for Reliability), Cytiva
Rated 5 out of 5
It was an honor and a privilege to speak at the Why Summits Conference. The entire event was informative and engaging; and executed in the utmost excellence.
Kelvin Roddy
Ph.D, MBA, R&D Director Program and Portfolio Management, Alexion Pharmaceuticals
Rated 5 out of 5
I truly enjoyed being the moderator on the conference and was amazed by the quality of speakers and the insights that were shared.
Anita Burrell
Principal, Anita Burrell Consulting
Rated 5 out of 5
Had a wonderful time at the Why Summits 23rd American Pharma & Biotech Project, Program, and Portfolio Conference in Boston last week. Engaging with fellow professionals in project/program/portfolio management within the biopharma/life sciences industry was truly insightful. Excited to have shared best practices and gained valuable insights!
Tonye Medley, PhD
PMP, Senior CMC Project Manager, Bristol Myers Squibb
Rated 5 out of 5
My thanks to Why Summits for the invite to provide a Keynote Presentation and chair Day One of the conference. It was so much fun to interact with a knowledgeable audience and some truly insightful speakers.
Anita Burrell
Principal, Anita Burrell Consulting
Rated 5 out of 5
Had a great time participating on a panel discussing "Mastering Governance and Risk in Pharma & Biotech" at the Why Summits 23rd American Pharma and Biotech Project, Program, and Portfolio Management Conference in Boston alongside Brandie Jonas, Kristen Bequeath, and Uma Staehler.
Stephen Smith
Senior Program Director, Oncology, Corcept Therapeutics
Rated 5 out of 5
Had the opportunity to attend the Why Summits Pharma and Biotech Project, Program and Portfolio Management Conference in Boston. The keynote sessions and panels were incredibly informative. The event showcased numerous innovative technical products and tools that harness the power of AI, enhancing the efficiency of Project, Program, and Portfolio management.
Lavanya Ranganathan
Sr IT Program Manager, Bristol Myers Squibb
Rated 5 out of 5
I just returned from a few days with fellow Portfolio and Project management colleagues in Biotech/ life sciences as part of the Why Summits PPM conference at Boston. From being a speaker, to a panelist across a few topics and engaging with such an experienced group of professionals was a great learning experience overall.
Anusha Sivaramakrishnan
Executive Director, Head - Enterprise Project Management and Governance, Arvinas
Rated 5 out of 5
Why Summits love being a part of #whysummits! Great job organizing such a rich program!
Lulu Yang
Enabling Leader for the Regulatory Business Office; People, Growth and Transformation Leader, Roche/Genentech
Rated 5 out of 5
Great discussions and a lot of learnings from everyone!
Shalima Sreenath
Head of Downstream Processing, Cellibre
Rated 5 out of 5
It was a pleasure to chair a very successful and productive Day 1 of the Why Summits meeting in Las Vegas today. Many thanks to the panelists for sharing your experience and best practices in data management and analytics, strategic risk management, and nurturing talent, innovation, development, growth, and success. (…)
Stephen Smith
Senior Program Director, Oncology, Corcept Therapeutics
Rated 5 out of 5
What a terrific event Why Summits put on last week in Las Vegas! I had the pleasure to present and to sit on several panels over the course of the three days, focusing on Portfolio decision-making, risk, and new tools to enhance the work we do. Many thanks to all the excellent presenters, Stephen Smith and Dave Penndorf for their excellent hosting and facilitation. Looking forward to next time!
Matthew Azzara
Head, Oncology Global Portfolio Management, EMD Serono, Inc
Rated 5 out of 5
Great to share thoughts, ideas, and experiences with other PMO leaders… Thank you all for the opportunity to engage!
John Michelot
Senior Director Project Management, Edwards Lifesciences
Rated 5 out of 5
I had an amazing time in Vegas last week at the Portfolio Conference by Why Summits, a gathering for industry professionals in the pharma and biotech industry where I delivered a keynote on "Crafting a Competitive AI Strategy in Life Sciences: Approach Recommendations Using the NIH All of Us Program as a Case Study." It was incredibly exciting to share insights from the AI strategy work I've been doing at the NIH All of Us program for the first time. I also led two AI roundtables on strategic decision-making and participated on a panel about "The Art and Science of Decision Making in Biotech.” (…) It was fantastic to meet so many inspiring individuals pushing the boundaries of innovation in this space.
Talia Grace Haller
Strategic AI Adviser to the Chief Medical and Scientific Officer, The National Institutes of Health/Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Rated 5 out of 5
Wrapped up the Why Summit Conference on Project Management, Portfolio Management, and CAPEX in Las Vegas today. Great conference and interactions with all of the attendees! Thank you all for connecting and interacting. Fantastic group of folks that I met there!
Thomas Seener
Executive Director, The One Project Source, LLC
Rated 5 out of 5
It’s been a pleasure to be a presenter and panelist for 4 topics at the #WhySummits in Las Vegas this week. Lots of great learnings and sharing of ideas by the participants. Now I’m re-energized to put some of these thoughts into action with my teams!
Lulu Yang
People, Growth and Transformation Leader, Roche/Genentech
Rated 5 out of 5
Yet another wonderful Why Summits Project and Portfolio Management event. I gain so much from the opportunities to speak to such a receptive and participative audience of diverse colleagues from across the pharma and biotech industries. Meeting new people through engaging conversations and inevitably learning from one another. (...) I am not affiliated with WhySummits, I simply find their events to be consistently high quality and professionally valuable.
Tim Rumbaugh
Vice President, Program Management, Edwards Lifesciences
Rated 5 out of 5
Another Why Summits PPM is in the books, this time in fabulous Las Vegas! I really enjoyed reconnecting with friends and making new connections. And one thing is sure: Vegas will always present a photo op!
Magnus Ytterstad
Product owner, Head of Customer Success and Portfolio Analytics, Captario
Rated 5 out of 5
Audience was great, maybe more variety in industry areas. It can be enlightening to learn from other industries
Delphine Demeestere
Director of External Innovation, Lonza
Rated 5 out of 5
You had CMOs, CROs, biotechs, and big pharma all in one room. That created richer discussions.
Romain Hahn
Global Partnering Lead, Roche
Rated 5 out of 5
Every conversation I had was relevant. I walked away with clear follow-up actions or next steps.
Benjamin Fischer
VP Global Alliance & Integration Management, STADA Group
Rated 5 out of 5
The Insilico talk on AI clearly showed how important solutions beyond the molecule are - to solve problems like improving adherence and reducing dropouts.
Marcel Wuethrich
Global Chief Commercial & Business Development Officer, evoleen
Rated 5 out of 5
It was especially interesting to hear from one of the companies that managed to move from AI into clinical development candidates.
Luis Correia
Founder and CEO, Basel Biotech Consulting Gmb
Rated 5 out of 5
The application of AI in drug development and the potential for future diagnostics - that’s a personal favorite. I truly believe it has the potential to revolutionize how we do drug development.
Isabella Visconti
Founder, Visconti Alliance Management
Rated 5 out of 5
I thoroughly enjoyed the interactive and spontaneous discussions on key pharmacovigilance topics, ranging from Gen AI to PV regulatory frameworks. The conference brought together a focused group of PV professionals, providing ample opportunities to connect and network with like-minded individuals. Overall, it was a successful conference and met its objectives.
Karthik Babu
Consumer Healthcare Global PV Operations Head, Sanofi
Rated 5 out of 5
Participating in the American Drug Safety Summit was a truly rewarding experience. The energy in the room, the depth of conversations, and the shared commitment to transforming pharmacovigilance made it an inspiring and impactful event. I walked away with new perspectives, meaningful connections, and a strong sense of momentum for what’s ahead.
Gigi Atalla​​​​
Vice President, Head of Global Drug Safety & Pharmacovigilance, Genmab
Rated 5 out of 5
I thoroughly enjoyed participating in the Why Summits pharmacovigilance conference. The topics were not only timely and relevant but also deeply engaging, sparking meaningful discussions. I especially appreciated the collaborative atmosphere, which created a great opportunity to connect with colleagues across the field and exchange valuable insights.
Mina Ebeid 
Director, Global Drug Safety, Genmab
Rated 5 out of 5
The conference fosters invaluable connections and drives meaningful collaboration, offering an engaging platform for dynamic interactions within Global Pharmacovigilance & Risk Management, exchange of ideas, and shared growth among participants to ensure patient safety and regulatory compliance.
Kal Elhoregy, RPh., PA.
Senior Director, Global Risk Management, Amneal
Rated 5 out of 5
The American Drug Safety Summit 2025 was a great event to learn from industry experts about the evolution of patient safety. It was very interesting to see how AI is being leveraged in data-intensive projects to improve patient outcomes. The introduction to the REMS Industry Consortium was a highlight, and their work is truly inspiring.
Apoorva Anil Joshi
Senior Pharmacovigilance Product Scientist, Genentech
Rated 5 out of 5
I want to express my gratitude to Lubos and the Why Summits team for a well-organized and informative Pharmacovigilance event. The comprehensive agenda, featuring a variety of expert presenters and engaging panel discussions, provided valuable insights and fostered productive networking. I'm eager to participate in future Why Summits events.
Israel Bocanegra
Associate Director, Business Development, Pharmacovigilance Technology Solutions
Rated 5 out of 5
Attending this year American Drug Safety Summit 2025 in Boston by Why Summits was an absolute discovery for me. Attendees were not numerous but they represented top-notch leaders from pharma industry in the EU and USA. Discussions were so exciting and constructive - I enjoyed every moment of it. I am truly grateful to Jan, Lubos and Zuzana for such a smart planning of this important event.
Maja Barac
Director, EU Qualified Person for PV, PharmaVigil
Rated 5 out of 5
This event provided great opportunity to network with Industry peers & thought leaders and explore new ways of working. Especially in the new AI era; “on  how Pharmacovigilence industry is progressing and how we need to adapt to the change”. Insights from presentations and panel discussions are adorable . I left with great ideas and new connections in my network to collaborate with and grow further.
Vasudev Sureddy
Executive Director & COO, ADVITY RESEARCH
Rated 5 out of 5
Fabulous meeting today, Lubos. This is a fabulous opportunity for us to shape the future, not just that we can be the conduit to current advances, but we can go beyond that with our military grade solutions.
Robert Huber
Co-Founder and Chief Product Officer, Veridat
Rated 5 out of 5
I heard great things about the event from those who attended, and those who didn't manage to attend this year regret.
Katarina Ilic
Expert Consultant, Drug Safety, Clinical Pharmacology, Clinical Development, Pharmacoepidemiology
Rated 5 out of 5
Excited to have participated in the American Drug Safety Summit in Boston, MA! 🌟 It was an honor to highlight the successful partnerships and collaborations between our Safety and Social teams over the past couple of years as well as connect and learn from with industry Subject Matter Experts. A key takeaway for me: AI is coming/ AI is now- How can we utilize this tool, not only to bring efficiencies into our work, but also focus on value-add and increasing quality of work? Thank you to Alison Purdon for your sponsorship and mentorship over the past several years and inviting me to join in on this opportunity! Thank you to Lubos K.and the #WhySummits team for all of your partnership and efforts creating a memorable event!
Marissa StLouis
Safety Partnering Lead, Genentech
Rated 5 out of 5
The event was incredibly well-organized, and we enjoyed both the thoughtful conversations and the chance to connect with others in the industry. Your efforts in bringing together leaders in drug safety to drive meaningful dialogue do not go unnoticed, and we are grateful to have been a part of it. Thank you again for your kind invitation and for making the experience such a great one. I look forward to staying in touch and continuing the conversation!
Alison Purdon
Senior Director, MedOps, Quality & Compliance, Engagement Oversight, Genentech
Rated 5 out of 5
WhySummit's Pharmacovigilance Conference in Boston exceeded expectations for all. As chair, I was impressed by the intimate scale and quality of interactions given how tricky it can be to strike the right balance of being large enough to bring together diverse perspectives and new connections, yet small enough to foster meaningful dialogue and substantive interactions. Both sponsors and attendees valued lively discussions that went beyond typical sessions (and without being overly 'salesy'). Lubos and his team deserve credit for curating a program that was both informative and interactive, creating an environment where PV professionals could truly connect, share and learn from each other. Looking forward to next year!
Andrew Mitchell
Chief Executive Officer, YEZA.ai
Rated 5 out of 5
Really enjoyable day today! Listening and participating in these different sessions was really great! I think it’s also much better than other conferences that I have attended, because the engagement and participation from the audience is active and really on point! Thanks all for pulling this together! 
Thomas Seener
Executive Director , The One Project Source, LLC 
Rated 5 out of 5
An outstanding few days of industry relevant PPM topics, from the energetic and thoughtful speakers and panels to networking new relationships to insights into where the industry is going with AI! Huge chops to Why Summits? for putting on an engaging and professional event!
Mike Fitzpatrick
Vice President of Business Development & Operations , Umoja Biopharma 
Rated 5 out of 5
Fascinating conference with seasoned and insightful industry leaders sharing perspectives into a wide range of topics across program and portfolio management. It was the perfect size – around 120 people – big enough to attract diverse and talented people, but small enough for everyone to engage in meaningful networking. We ended each day with roundtable discussions - small table discussions with the speakers and each other, which allowed us to both learn from each other and get to know our peers. Overall, a great experience and I look forward to returning. 
Rebecca Rudicell, PhD. 
Translational Program Management (Oncology), Takeda
Rated 5 out of 5
It was a fantastic experience presenting at the Why Summits PPM conference in Boston. An excellent opportunity to connect with industry experts and exchange valuable insights on various aspects of Project and Portfolio Management in Healthcare R&D.
Mark Zhang
Senior Director, Head of Global Program Management Oncology, EMD Serono
Rated 5 out of 5
This was my first time at the Why Summits, and it exceeded my expectations. We met many existing clients and had phenomenal interactions, appreciating the well-organized format that encouraged engagement. Key takeaways include the impressive quality of presenters, excellent networking opportunities with both new and existing clients, and valuable insights from a session on emotional intelligence by Kelvin Roddy, which highlighted the importance of connection and thoughtfulness in our engagements. I highly recommend this conference to colleagues as a well-structured event that fosters meaningful connections. We look forward to participating in more events like this in the future.
Rishi Dixit
Vice President, Strategic Solutions (Innovative Products and Partnerships), Atlas
Rated 5 out of 5
It was an honor to speak at the 23rd American Pharma and Biotech Conference in Boston, sharing how Intelligencia AI is transforming decision-making in pharma and biotech with data-driven solutions. Thank you to everyone who joined and contributed to the engaging discussions. If you’d like to learn more about our approach, feel free to reach out!
Marianna Esposito
Director, Business Development, Scientific Liaison Director, Intelligencia AI
Rated 5 out of 5
This conference was exceptional, featuring a diverse group of attendees, all of whom are experts in their fields. The event attracted a strong cross-section of the industry, encompassing both large and small companies. The networking opportunities were invaluable, allowing me to connect with a wide range of professionals and expand my network significantly. I wholeheartedly recommend this conference and plan to attend more events next year. It truly exceeded my expectations, with outstanding attendance and presentations throughout all three days. This conference has established itself as the premier event in the resource planning space, showcasing our commitment to excellence in the industry.
Phil Wolf
SVP, On Demand Products, PDWare
Rated 5 out of 5
It seems like forever ago, yet it was only two weeks ago that I had the pleasure of presenting at Why Summits in Boston on the power of Planisware and our AI capabilities regarding risk management. The engagement was lively, and the content of the conference was spot on. Be on the lookout for other opportunities to join such events later this year and in 2025!
Aimee Rodrigues
Vice President- Life Sciences PPM Practices, Planisware
Rated 5 out of 5
Wrapping up an extraordinary Day 3 at the 23rd American Pharma and Biotech PPM Conference! Our Founder and CEO, Sandeep Kumar, delivered an inspiring session on “Accelerating Time-to-Market in Pharma NPD: The Role of AI in Project Management.” His insights into leveraging AI for faster, more efficient pharma product development left the audience buzzing with excitement and possibilities! It’s been a phenomenal journey of learning, innovation, and connections. Here’s to continuing the momentum and driving change in the biotech and pharma industries!
Sandeep Kumar
Founder & CEO, Kytes
Rated 5 out of 5
I am truly honored to have had the opportunity to moderate such an engaging and thought-provoking panel discussion on "addressing challenges in signal detection and risk management" and "addressing inconsistencies in data reporting and leveraging technology solutions, how technology can help ? at WHY SUMMITS, GLOBAL DRUG SAFETY SUMMIT, MUMBAI
Dr. Deepak S.
MD, Director, Pharmacovigilance- Medical Scientific Unit, Teva Pharmaceuticals
Rated 5 out of 5
Enjoyed it lot. Thanks Why Summits.
Dr. Shubhadeep D Sinha
Senior Vice President CD&MA
Rated 5 out of 5
I had the privilege of sharing the stage with industry experts at the recent Global Drug Safety & PV Outsourcing Summit, organized by Why Summits on the topic of ‘Challenges in Signal and Risk Management'. The event featured in-depth discussions on a range of topics, including end-to-end pharmacovigilance activities, advances in signal detection, affiliate management, evolving regulations, and more, all offering valuable insights.
Dr. Santosh Hulawale
Senior Manager- SERM & PvOI (India), Glenmark Pharmaceuticals
Rated 5 out of 5
Last week, Attended “Global Drug Safety and PV Outsourcing Summit 2024, Mumbai” as a Speaker and addressed on topic “Advances in Signal Detection & Risk Management”. It was a mesmerizing experience ! Thank you Why Summits and Lubos Kusy for inviting !
Dinesh Wagh
Manager, Safety Submissions (Clinical Trials), Precision For Medicine
Rated 5 out of 5
Just wrapped up an incredible experience at the Global Drug safety & PV Outsourcing Summit and AI tools (22 to 23-Oct-2024 in Mumbai). A huge thank you to the organizers #whysummit for their exceptional hospitality and for creating such a welcoming and engaging atmosphere. The insights shared and the connections made were invaluable. From innovative solutions to thought-provoking discussions on the future of outsourcing, this event truly exceeded my expectations.
Ismail Ahmed
Deputy Manager, Viatris
Rated 5 out of 5
I had the privilege of attending the Global Drug Safety and PV Outsourcing Summit on 22-23 October 2024 in Mumbai. It was an incredibly insightful event, packed with valuable discussions and forward-thinking ideas. While many topics were discussed, I found the following particularly important: Cost Center vs. Cost-Effective, Patient-Centric PV, Biosimilars and PV, Leveraging AI and LLM
Sunil Thakur
Sr. Manager - Medical Affairs and QPPV, Exeltis India
Rated 5 out of 5
It seems like forever ago, yet it was only 2 weeks when I had the pleasure of presenting at Why Summits in Boston on the power of Planisware and our AI capabilities regarding risk management. The engagement was lively and the content of the conference was spot on. Be on the look out for other opportunities to join such events later this year and in 2025!
Aimee Rodrigues
Vice President- Life Sciences PPM Practices, Planisware
Rated 5 out of 5
It was such a great conference with great people and great learnings. I am looking forward to the next one.
Luvanka Hanxhari
Global RMP Lead, Novartis
Rated 5 out of 5
What an excellent 2-day event connecting with friends and industry colleagues, old and new. There was plenty to digest, lots of learnings and take home messages whilst we shared best practices. Looking forward to the next one!
Nick Nikberg
Senior Pharmacovigilance Professional, Astra Zeneca
Rated 5 out of 5
Thanks to the 9th Global Pharmacovigilance & RWE Forum speakers, for sharing their knowledge and experience. It was a great first Pharmacovigilance conference and a good chance to meet more like-minded people in the industry.
Cláudia Meneses
Senior Pharmacovigilance Officer, Sanofi
Rated 5 out of 5
It was such a great conference with great people and great learnings. I am looking forward to the next one.
Luvanka Hanxhari
Global RMP Lead, Novartis
Rated 5 out of 5
A huge shout out to Why Summits for the terrific organization, bringing all these talented people together. Great minds, great conversations, great topics. Buckling up for the next 😄.
Erika Barbarosie
Associate Director PV Compliance, Gilead Sciences
Rated 5 out of 5
I have thoroughly enjoyed the past 2 days of networking with my colleagues and industry professionals. Thank you to Why Summits for wonderful organisation!
Lewis Atkinson
Director of Business Development EMEA, IQVIA
Rated 5 out of 5
The pragmatic discussions truly reflected ground realities, and the practical tips provided were invaluable. Kudos to the organiser Why Summits for the excellent choice of topics and for bringing together the experts to address the real-world challenges in utilizing real-world evidence for patient safety.
Sanjeev Srivastav
Signal Management Lead, BioNTech
Rated 5 out of 5
Really enjoyed the Pharmacovigilance & RWE Forum by Why Summits! What I loved most, is how friendly, collaborative and intimate the PV community really is. This is of course great to see, as a vendor, but more so a potential patient receiving the outputs of this heroic work!
Souhail Debaghi
Director of Sales, TriNetX
Rated 5 out of 5
Thank you Why Summits for the opportunity to share my thoughts on Advancements & Challenges in Signal Detection. It was great to share my thoughts along with other panelists.
Vijay Singh
Associate Director, Product PV Device Digital Safety, UCB
Rated 5 out of 5
Thanks to the 9th Global Pharmacovigilance & RWE Forum speakers, for sharing their knowledge and experience. It was a great first Pharmacovigilance conference and a good chance to meet more like-minded people in the industry.
Cláudia Meneses
Senior Pharmacovigilance Officer, Sanofi
Rated 5 out of 5
What an excellent 2-day event connecting with friends and industry colleagues, old and new. There was plenty to digest, lots of learnings and take home messages whilst we shared best practices. Looking forward to the next one!
Nick Nikberg
Senior Pharmacovigilance Professional, Astra Zeneca
Rated 5 out of 5
Arlène Derbaix
Vice President, Clinical Operations & Product Development Operations, Program and Portfolio Management, CureVac
Rated 5 out of 5
Put on by Why Summits in San Francisco, this was an awesome opportunity to speak to a pharmaceutical / biotech audience. The top reason for anyone to attend a conference is to meet new people, understand how your work lives differ & intersect, and applying what you learn from everyone’s experience & expertise. And as a speaker, I also get a great big dose of clarity on how I can improve next time.
Tim Rumbaugh
Vice President, Program Management, Edwards Lifesciences
Rated 5 out of 5
At last week's Why Summits Biotech and Pharma PPM meeting, I met with PMs from a variety of different companies to learn more about how they plan drug discovery projects and some of the challenges they face. Here are some of the key takeaways.
Mark Fortner
Founder and Chief Executive Officer, Aspen Biosciences
Rated 5 out of 5
Had the pleasure of participating in a panel discussion today at ‘2nd Strategic Project, Program and Portfolio Management conference for Pharmaceuticals’ organised by Why Summits on the critical role of internal stakeholders in driving project success. Grateful to have exchanged insights with industry leaders on how to build these connections and unlock potential from within. We continuously strive to implement these best practices at Neuland Laboratories Limited.
Abhishek Mittal (MBA, PMP®, IRMCert®, GRCP®)
Vice President and Head - Project Management Office (PMO), Neuland Laboratories Limited
Rated 5 out of 5
I had the pleasure of assisting this year to the first two days of the Portfolio Summit in Basel, where +100 colleagues of +30 companies, discussed the topics of Portfolio, Projects, and CapEx in a very open and inviting environment. (Big thanks to Why Summits and especially to Liza Zhaivoronok for your help). I am very much looking forward to the 2025 Summit!
Carlos Cabrera
Head of Finance and Resources - Portfolio Creation and Technology, Bayer
Rated 5 out of 5
Another great Why Summits conference in the books!
Stephen Smith
Senior Program Director, OncologySenior Program Director, Oncology, Corcept Therapeutics
get the latest updates & discounts

SubScribe to our newsletter

WHY SUMMITS

Conference
10-Pack for Teams

10 Tickets for your team

One package. Access to any Why Summits’ conferences, with flexible selection via email throughout the year.

$9,990 / €9,990

Please note: This offer is not applicable to solution providers, software vendors, or consulting companies.

Not sure which conferences to choose for your team?

Leave your details and our team will help you plan the best conference mix for 2026.

Submission Successful!

Your information has been received.